Junhong Zhao Selected Research

Junhong Zhao Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 06/2010
4	Stomach Neoplasms (Stomach Cancer) 04/2018 - 02/2012
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 09/2013
3	Carcinogenesis 02/2015 - 06/2010
2	Glaucoma 10/2021 - 09/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 02/2018
2	Colitis 11/2019 - 02/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 09/2013
2	Hepatocellular Carcinoma (Hepatoma) 03/2013 - 06/2010
2	Clonorchiasis 08/2012 - 06/2012
2	Fibrosis (Cirrhosis) 06/2010 - 10/2009
1	Blindness (Hysterical Blindness) 10/2021
1	Bites and Stings (Sting) 01/2021
1	Ulcer 01/2021
1	Inflammation (Inflammations) 01/2020
1	Weight Loss (Weight Reduction) 03/2019
1	Stroke (Strokes) 11/2015
1	Insulin Resistance 03/2015
1	Adenocarcinoma 06/2014
1	Neoplasm Metastasis (Metastasis) 03/2013
1	Body Weight (Weight, Body) 03/2013
1	Epstein-Barr Virus Infections 01/2013
1	Fatty Liver 06/2010
1	Infections 06/2010

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2013
3	PPAR gammaIBA 03/2013 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2012
2	Transcription Factors (Transcription Factor)IBA 04/2018 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 04/2018 - 06/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2013 - 06/2010
2	Immunoglobulin G (IgG)IBA 08/2012 - 06/2012
2	AntigensIBA 08/2012 - 06/2012
2	Rosiglitazone (Avandia)FDA Link 06/2010 - 06/2010
1	cytoplasmic protein A (PACD)IBA 10/2021
1	Rabeprazole (Aciphex)FDA Link 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2021
1	InterferonsIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	InflammasomesIBA 01/2021
1	pyrimidin-2-one beta-ribofuranosideIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 11/2019
1	Phosphodiesterase InhibitorsIBA 11/2019
1	Dipyridamole (Persantine)FDA LinkGeneric 11/2019
1	AcidsIBA 03/2019
1	SolutionsIBA 03/2019
1	Indicators and Reagents (Reagents)IBA 02/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2018
1	Dextran SulfateIBA 02/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2015
1	Insulin (Novolin)FDA Link 03/2015
1	Blood Glucose (Blood Sugar)IBA 03/2015
1	Glucagon (Glukagon)FDA Link 03/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014
1	ribonucleotide reductase M2IBA 06/2014
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Biological ProductsIBA 06/2014
1	Small Interfering RNA (siRNA)IBA 06/2014
1	CateninsIBA 03/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2013
1	SERPIN-B5 (maspin)IBA 03/2013
1	Interferon-alpha (Interferon Alfa)IBA 03/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2013
1	Cyclin D1IBA 03/2013
1	Metalloproteases (Metalloproteinases)IBA 03/2013
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2013
1	OligonucleotidesIBA 03/2013
1	Caspase 8 (Caspase-8)IBA 03/2013
1	Granzymes (Granzyme)IBA 03/2013
1	oxidized low density lipoproteinIBA 03/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Cell Adhesion MoleculesIBA 01/2013
1	Mitogen-Activated Protein KinasesIBA 01/2013
1	Therapeutic UsesIBA 06/2012
1	EnzymesIBA 06/2012
1	Peptide Hydrolases (Proteases)FDA Link 06/2012
1	ImmunosorbentsIBA 06/2012
1	Cathepsin LIBA 06/2012
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 02/2012
1	Choline (Choline Chloride)IBA 06/2010
1	Methionine (L-Methionine)FDA Link 06/2010
1	Connective Tissue Growth FactorIBA 06/2010

Therapy/Procedure

4	Therapeutics 01/2018 - 02/2012
1	Immunotherapy 01/2021
1	Oral Administration 02/2018
1	Electroacupuncture 11/2015
1	Lasers (Laser) 09/2013